Mitchell J. Blutt, MD
CEO and CIO

Mitchell Blutt – Managing Partner & Co-Founder

Mitchell Blutt, MD is the CEO of Consonance Capital, a health care focused investment firm. He is the former Executive Partner of J.P. Morgan Partners (JPMP). He is a Clinical Assistant Professor of Medicine, in the Department of Medicine at Weill Cornell Medicine.

Dr. Blutt completed his BA and MD degrees at the University of Pennsylvania and he received his MBA from the Wharton School of the University of Pennsylvania through the Clinical Scholars Fellowship sponsored by the Robert Wood Johnson Foundation. He completed his residency in Internal Medicine at New York-Presbyterian/Weill Cornell Medical Center.

Dr. Blutt has served on numerous boards of directors, including Cardinal Health, Cooper Holding, DJ Orthopedics, Fisher Scientific, General Medical, Hanger Orthopedic Group, Medical Arts Press, Tenax, Thermoscan and KEPRO. He also formerly served on the Board of the Michael J. Fox Foundation for Parkinson’s Research, the Board of Trustees of Penn Medicine (the Health System of the University of Pennsylvania), the Board of Trustees of the University of Pennsylvania, and the Board of The Brearley School. He currently serves on the Board of Overseers of the School of Arts and Sciences and is the Chairman of the External Advisory Board of CHIBE (Center for Health Incentives and Behavioral Economics) at the University of Pennsylvania. Dr. Blutt is a recipient of the Alumni Award of Merit, the University of Pennsylvania’s highest honor. He serves on the Board of Overseers of Weill Cornell Medicine and is on the Executive Committee of the Dean’s Council, an advisory board to the Dean. Dr. Blutt is also a member of the New York Weill Cornell Council, an advisory board to the New York-Presbyterian/Weill Cornell Medical Center. Additionally, he serves on the Board of Directors of The Commonwealth Fund, a private foundation that supports independent research on health and social issues and makes grants to improve health care practice and policy. Dr. Blutt also serves on the Board of Bako, a premier national provider of specialty laboratory testing and other high quality pathology services, and PMC (Psychiatric Medical Care), the leading operator of inpatient and outpatient behavioral health programs in rural communities.

Dr. Blutt founded Consonance Capital in 2005.

Benny Soffer, MD
Partner and Portfolio Manager

Dr. Benny Soffer – Founding Partner & Co-Portfolio Manager

Dr. Benny Soffer is a Founding Partner and Member of the Investment Committee and Portfolio Manager of Consonance Capital Management and was an original employee in September 2005. Prior to Consonance, Benny completed a residency in internal medicine at Yale and served in a variety of managerial roles at Yale-New Haven Hospital, including as Medical Director of Clinical Process Improvement and as Interim Medical Director of Medical Information Systems.

Benny is a Clinical Assistant Professor of Medicine, in the Department of Medicine at Weill Cornell Medical College. Benny is a graduate of Williams College, where he received his BA, of Emory University, where he received his MD, and of Yale University, where he received his MBA.

Kevin H. Livingston
Partner

Kevin H. Livingston - Partner

Kevin Livingston is a Founding Partner and Member of the Investment Committee of Consonance Capital Management and was an original employee in September 2005. Prior to Consonance, Kevin was a Managing Director in the Investment Management Division at U.S. Trust Company of New York. At U.S. Trust, Kevin managed client capital in discretionary multi-manager portfolios, and was a Member of the Open Architecture Investment Committee. Kevin currently serves on the board of directors of DC Safety. He is a Trustee of Alfred University and serves as the Chair of the Investment Committee.

Kevin is a Certified Public Accountant and a graduate of Alfred University, where he received his BS. He also received his Executive MBA from Columbia Business School.

Damien Nguyen
Analyst

Damien Nguyen – Investment Analyst

Damien Nguyen joined Consonance in 2016 and works as an investment analyst. Prior to joining Consonance, he was most recently an investment analyst at an institutional family office on its healthcare team and was previously an investment analyst at a healthcare-focused hedge fund. Damien began his career as an Analyst at Morgan Stanley in their healthcare investment banking group. He holds a BA from Northwestern University.

Slanix Paul Alex
Analyst

Slanix Paul Alex – Analyst

Slanix Paul Alex, PharmD joined Consonance in 2018 as an investment analyst. Previously, Slanix worked in equity research at the Royal Bank of Canada and Credit Suisse, where he conducted investment research on both commercial and development stage biotech companies. Prior to his career in finance, Slanix worked in strategy consulting at a life sciences-focused firm, where he conducted and led numerous business development and commercial strategy projects for pharma, biotech, medical devices, and diagnostics clients. Slanix is a pharmacist by training, and received his Doctor of Pharmacy degree from St. John’s University.

Alexander Man
Analyst

Alex Man– Investment Analyst

Alex Man joined Consonance in 2019 as an investment analyst. Prior to Consonance, he worked in equity research, covering Global Pharmaceuticals at Wolfe Research and Sanford C. Bernstein. Alex started his career as a strategy consultant with Simon-Kucher & Partners where he advised biopharma clients on market diligence, revenue maximization, and commercial strategy. He holds a BA from the University of Rochester.

Maria de León
CCO

Maria de León joined Consonance as their Chief Compliance Officer in October 2019.

Maria de León joined Consonance as their Chief Compliance Officer in October 2019. Prior to joining Consonance, she was the Chief Compliance Officer and Chief Operating Officer at Chesapeake Asset Management, LLC. From 2007-2017, Maria was a Director of the Legal & Compliance Team at Blue Ridge Capital, L.L.C. Prior to her time at Blue Ridge, Maria worked at Moore Capital Management leading the internal audit function in preparation for SEC registration. In 1998, Maria joined JP Morgan Partners as their Compliance Officer and was responsible for regulatory filings related to JPMP's portfolio. During her tenure at JP Morgan Partners, Maria also co-created the Risk Management/Audit team. From 1995-1998, Maria was a Senior Compliance Officer at Citigroup’s Legal Department. Prior to Citi, she was a member of the Mergers and Acquisitions Group at White & Case, LLP where she split her time between the New York and Mexico City offices. Maria holds a BA from The University at Albany.

Edward J. Cook
Compliance Consultant

Edward Cook - Compliance Consultant

Edward Cook joined Consonance in February 2016 as the Chief Compliance Officer and now serves as our Compliance Consultant. Previously, Ed served as the CCO to Solar Capital Partners, Broadmark Asset Management and CM Investment Partners while working for Alaric Compliance Services from 2007 until joining Consonance. From 2004 to 2007, Ed worked at the Department of Homeland Security where he was Counsel to the head of Immigration and Customs Enforcement. He served in the United States Navy in the Judge Advocate General’s Corps, on active duty and in the Reserves, for over twenty years, having most recently held the rank of Commander. He began his career at the law firm of Cahill Gordon and Reindel, where his practice included securities litigation for a number of prominent financial services industry clients. Ed is admitted to practice law in New York. He holds an AB from the College of William and Mary and a JD from the University of Virginia School of Law.

Gabriela J. Franco-Boland
CFO

Gabriela J. Franco - Controller

Gabriela Franco-Boland is the Chief Financial Officer of Consonance Capital Management. Gabriela joined the team in November 2006. Prior to joining Consonance, Gabriela was a Marketing Assistant at the New York Knicks and a Floor Director at the New York Rangers. Gabriela is currently a member of the New York State Society of Certified Public Accountants. Gabriela holds a BS and a BA from St. John’s University and an MBA from the Gabelli School of Business at Fordham University.

Gary Garofalo
Head Trader

Gary Garofalo – Head Trader

Gary Garofalo joined Consonance in September 2015 and works as the Head Trader. Prior to joining Consonance, Gary was the Head Trader at a New York-based Multi Family Office, Managing Director and Head of Trading at Eastwind Global Partners, and the Co-Head Trader at S Squared Technology, a TMT and Healthcare fund. Gary holds a BA from Fordham University.

Brianne Shergill
Operations Manager

Brianne Shergill – Operations Associate

Brianne Shergill joined Consonance in January 2009 and works as the Operations Manager. Prior to Consonance, Brianne was an office manager & project administrator for an engineering firm based in Chappaqua, NY and has also worked as an Accounting Assistant for The Jordan Company, LP, a private equity firm. Brianne holds a BBA from Berkeley College and an MBA from Nyack College.

Jessica Kim
Senior Accountant

Jessica Kim

Jessica Kim joined Consonance in July 2017 and works as a Senior Accountant. Prior to joining Consonance, she was a Senior Accountant at a New York-based family office, Fund Accountant at Moore Capital Management, and Financial Services Auditor at Ernst & Young. Jessica is a certified public accountant in New York State. She holds a BS and MS from the University of Virginia.

Gary Garofalo
Head Trader

Gary Garofalo – Head Trader

Gary Garofalo joined Consonance in September 2015 and works as the Head Trader. Prior to joining Consonance, Gary was the Head Trader at a New York-based Multi Family Office, Managing Director and Head of Trading at Eastwind Global Partners, and the Co-Head Trader at S Squared Technology, a TMT and Healthcare fund. Gary holds a BA from Fordham University.